BIOMAT Database Logo BIOMAT Database Logo

Effect of carrageenan-induced granuloma on hepatic cytochrome P-450 isozymes in rats. 1995

J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
Laboratory of Genetics and Biochemical Toxicology, Instituto di Mutagenesi e Differenziamento, CNR, Pisa, Italy.

Carrageenan-induced granuloma was used to study the apoprotein and RNA content, and catalytic activities of several cytochrome P-450 isozymes in liver. This model allowed discrimination between acute and chronic phases of experimental inflammation. The expression of most isozymes studied (CYP2D, CYP2E1, CYP3A1 and CYP4A) was reduced to 20% of the control level during the acute phase and partially recovered (30-60% of control group) during the chronic phase. CYP2B1 content was decreased to 65% of control during the acute and chronic phases of inflammation. RNA (CYP2B1 and CYP2E1) showed a strong depression during the acute phase and recovered during the chronic phase, without differences between isoenzymes. In most cases, there was a good correlation between the apoprotein content of isozymes and related activities. Our results show that the depletion of cytochrome P-450 induced by inflammation depends on the severity of the disease. Experimental inflammation equally affect the transcription of CYP2B1 and CYP2E1, so differences in apoprotein content and related activities between isozymes may due to differential posttranscriptional regulation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D002351 Carrageenan A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES. Carrageenin,iota-Carrageenan,kappa-Carrageenan,lambda-Carrageenan,iota Carrageenan,kappa Carrageenan,lambda Carrageenan
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
Effect of cannabidiol on cytochrome P-450 isozymes.
September 1989, Biochemical pharmacology,
J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats.
May 1988, Archives of biochemistry and biophysics,
J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
Effect of portacaval shunt on hepatic cytochrome P-450 in rats.
October 1972, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research,
J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
August 1987, Molecular pharmacology,
J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
Metabolism of tentoxin by hepatic cytochrome P-450 3A isozymes.
November 1997, European journal of biochemistry,
J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
Resolution of mouse hepatic cytochrome P-450 isozymes by chromatofocusing.
February 1986, Journal of chromatography,
J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
Identification of the hepatic cytochrome P-450 isozymes induced and decreased by picloram.
March 1988, Biochemical pharmacology,
J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
Characterization and regulation of rat hepatic microsomal cytochrome P-450 isozymes.
January 1984, Annals of the New York Academy of Sciences,
J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
On the glycosylation state of five rat hepatic microsomal cytochrome P-450 isozymes.
February 1983, The Journal of biological chemistry,
J Muntané, and V Longo, and M T Mitjavila, and P G Gervasi, and M Ingelman-Sundberg
Differential oxidase activity of hepatic and pulmonary microsomal cytochrome P-450 isozymes after treatment with cytochrome P-450 inducers.
September 1992, Biochemical and biophysical research communications,
Copied contents to your clipboard!